147 related articles for article (PubMed ID: 9649577)
1. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein.
Stoffers DA; Stanojevic V; Habener JF
J Clin Invest; 1998 Jul; 102(1):232-41. PubMed ID: 9649577
[TBL] [Abstract][Full Text] [Related]
2. Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene.
Lu M; Miller C; Habener JF
Endocrinology; 1996 Jul; 137(7):2959-67. PubMed ID: 8770920
[TBL] [Abstract][Full Text] [Related]
3. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.
Stoffers DA; Zinkin NT; Stanojevic V; Clarke WL; Habener JF
Nat Genet; 1997 Jan; 15(1):106-10. PubMed ID: 8988180
[TBL] [Abstract][Full Text] [Related]
5. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
[TBL] [Abstract][Full Text] [Related]
6. Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300.
Stanojevic V; Habener JF; Thomas MK
Endocrinology; 2004 Jun; 145(6):2918-28. PubMed ID: 15001545
[TBL] [Abstract][Full Text] [Related]
7. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
[TBL] [Abstract][Full Text] [Related]
8. Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells.
Marshak S; Totary H; Cerasi E; Melloul D
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15057-62. PubMed ID: 8986763
[TBL] [Abstract][Full Text] [Related]
9. The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.
Peshavaria M; Cissell MA; Henderson E; Petersen HV; Stein R
Mol Endocrinol; 2000 Dec; 14(12):1907-17. PubMed ID: 11117522
[TBL] [Abstract][Full Text] [Related]
10. Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity.
Liu A; Desai BM; Stoffers DA
Mol Cell Biol; 2004 May; 24(10):4372-83. PubMed ID: 15121856
[TBL] [Abstract][Full Text] [Related]
11. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus.
Habener JF; Stoffers DA
Proc Assoc Am Physicians; 1998; 110(1):12-21. PubMed ID: 9460079
[TBL] [Abstract][Full Text] [Related]
12. [Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus].
Małecki M; Krolewski AS
Przegl Lek; 2000; 57 Suppl 3():13-8. PubMed ID: 11293229
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
Shiau MY; Huang CN; Liao JH; Chang YH
J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the insulin gene by glucose: stimulation of trans-activation potency of human PDX-1 N-terminal domain.
Shushan EB; Cerasi E; Melloul D
DNA Cell Biol; 1999 Jun; 18(6):471-9. PubMed ID: 10390156
[TBL] [Abstract][Full Text] [Related]
15. Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1.
Schwitzgebel VM; Mamin A; Brun T; Ritz-Laser B; Zaiko M; Maret A; Jornayvaz FR; Theintz GE; Michielin O; Melloul D; Philippe J
J Clin Endocrinol Metab; 2003 Sep; 88(9):4398-406. PubMed ID: 12970316
[TBL] [Abstract][Full Text] [Related]
16. The homeodomain-interacting protein kinase 2 regulates insulin promoter factor-1/pancreatic duodenal homeobox-1 transcriptional activity.
Boucher MJ; Simoneau M; Edlund H
Endocrinology; 2009 Jan; 150(1):87-97. PubMed ID: 18772243
[TBL] [Abstract][Full Text] [Related]
17. Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family.
Cockburn BN; Bermano G; Boodram LL; Teelucksingh S; Tsuchiya T; Mahabir D; Allan AB; Stein R; Docherty K; Bell GI
J Clin Endocrinol Metab; 2004 Feb; 89(2):971-8. PubMed ID: 14764823
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor.
Waeber G; Thompson N; Nicod P; Bonny C
Mol Endocrinol; 1996 Nov; 10(11):1327-34. PubMed ID: 8923459
[TBL] [Abstract][Full Text] [Related]
19. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.
Malecki MT; Jhala US; Antonellis A; Fields L; Doria A; Orban T; Saad M; Warram JH; Montminy M; Krolewski AS
Nat Genet; 1999 Nov; 23(3):323-8. PubMed ID: 10545951
[TBL] [Abstract][Full Text] [Related]
20. Nuclear trafficking of photoreceptor protein crx: the targeting sequence and pathologic implications.
Fei Y; Hughes TE
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2849-56. PubMed ID: 10967037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
